Class 044: Medical analysis services; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services to support treatment decisions in cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms.
Class 044: Medical analysis services; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services to support treatment decisions in cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms.
Class 044: Medical analysis services; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for the prediction of side effects; medical analysis services for the prediction of side effects in a cancer patient; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for identification of new drug targets for the treatment of cancer drug side effects; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services for predicting drug side effects based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services for discovering new targets for overcoming side effects associated with cancer treatment, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms; medical analysis services for the prediction of cancer treatment side effects and the identification of associated biological mechanisms.
Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of host proteins; medical analysis services for discovering new targets to overcome cancer treatment resistance based on computational analysis of host proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services for the prediction of patients response to cancer treatment and the identification of associated biological mechanisms
Medicinal preparations for the treatment of cancer; diagnostic preparations for medical purposes; diagnostic kits comprising primarily diagnostic reagents for medical use in the field of oncology; Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for identification of new drug targets for cancer treatment; medical testing, analyzing and reporting services for diagnostic or treatment purposes in the field of oncology
Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of host proteins; medical analysis services for discovering new targets to overcome cancer treatment resistance based on computational analysis of host proteins
Medicinal preparations for the treatment of cancer; diagnostic preparations for medical purposes; diagnostic kits comprising primarily diagnostic reagents for medical use in the field of oncology | Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical testing, analyzing and reporting services for diagnostic or treatment purposes in the field of oncology
Medicinal preparations for the treatment of cancer; diagnostic preparations for medical purposes; diagnostic kits comprising primarily diagnostic reagents for medical use in the field of oncology; Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical testing, analyzing and reporting services for diagnostic or treatment purposes in the field of oncology
Medicinal preparations for the treatment of cancer; diagnostic preparations for medical purposes; diagnostic kits comprising primarily diagnostic reagents for medical use in the field of oncology; Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical testing, analyzing and reporting services for diagnostic or treatment purposes in the field of oncology
Cookie Preferences
We use cookies (including Google Analytics) to improve our site and understand how visitors use it.
